US03475V1017
US03475V1017
AngioDynamics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 320.174.000 | 292.498.000 | 9.5% |
| Cost of Revenue | 145.282.000 | 134.793.000 | 7.8% |
| Gross Profit | 174.892.000 | 157.705.000 | 10.9% |
| 197.221.000 | 181.767.000 | 8.5% | |
| Operating Income | -22.329.000 | -24.062.000 | 7.2% |
| Pretax Income | -36.300.000 | -34.032.000 | 6.7% |
| Net Income Common Stockholders | -36.742.000 | -33.993.000 | 8.1% |
| -- | -- | -- | |
| -- | -- | -- |